t-Darpp is an elongated monomer that binds to calcium and is phosphorylated by cyclin-dependent kinases 1 and 5
J. Momand, P. Magdziarz, Y. Feng, D. Jiang, E. Parga, A. Celis, E. Denny, X. Wang, M. L. Phillips, E. Monterroso, S. E. Kane, F. Zhou
Abstract
t-Darpp is a protein encoded by the PPP1R1B gene and is expressed in breast, colon, esophageal, gastric, and prostate cancers, as well as in normal adult brain striatal cells. Overexpression of t-Darpp in cultured cells leads to increased protein kinase A activity and increased phosphorylation of AKT (protein kinase B). In HER2+ breast cancer cells t-Darpp confers resistance to the chemotherapeutic agent trastuzumab. To shed light on t-Darpp function, we studied its secondary structure, oligomerization status, metal-binding properties, and phosphorylation by cyclin dependent kinases 1 and 5. t-Darpp exhibits 12% alpha helix, 29% beta strand, 24% beta turn and 35% random coil structures. t-Darpp binds to calcium, but not to other metals commonly found in biological systems. The T39 site, critical for t-Darpp activation of the AKT signaling pathway, is a substrate for phosphorylation by cyclin-dependent kinase 1 (CDK1) and cyclin-dependent kinase 5 (CDK5). Gel filtration chromatography, sedimentation equilibrium analysis, blue native gel electrophoresis, and glutaraldehyde-mediated crosslinking experiments demonstrate that the majority of t-Darpp exists as a monomer, but forms low levels (< 3%) of hetero-oligomers with its longer isoform Darpp-32. t-Darpp has a large Stokes radius of 4.4 nm relative to its mass of 19 kDa, indicating that it has an elongated structure.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Mechanistic Elucidation of the Antitumor Properties of a Novel Death Receptor 5 Activator
- Tristetraproline in breast cancer: treat or trick?
S. Kropyvko, A. Hubiernatorova, … A. Rynditch·bioRxiv·May 23, 2022
- Selective inhibition reveals the regulatory function of DYRK2 in protein synthesis and calcium entry
- Multi-site phosphorylation of the TOPBP1 ATR Activation Domain propels ATR signaling during the response to DNA breaks
H. Senebandith, K. Ruis, … W. M. Michael·bioRxiv·Sep 19, 2022
- Shared and distinct sequence-function signatures define different modes of human TpoR activation
Xinyu Wu, Harry McLeod, … Melissa J. Call·bioRxiv·Sep 9, 2025
- Structural basis of Cdk7 activation by dual T-loop phosphorylation
Robert Düster, K. Anand, … Matthias Geyer·bioRxiv·Feb 14, 2024